Circulating plasma microRNAs in sporadic Parkinson's disease
A research project funded by UEFISCDI
(contract no. PN-III-P2-2.1-PED-2016-0735)
Study type: Interventional
Study design: Allocation - non-randomized
Primary purpose - diagnostic
Primary outcome
Evaluate the diagnostic value of individual quantitative RT-PCR assay of plasma microRNAs in Parkinson's Disease (PD), by testing a discovery set of 15 microRNAs.
Secondary outcome
Evaluate the use of individual quantitative RT-PCR assays of plasma microRNAs in Parkinson's Disease (PD), to monitor the response to therapy in PD individuals, by testing a discovery set of 15 microRNAs.
Place of study:
Biochemistry Department of UMF Timisoara
Neurology Department of UMF Timisoara
Research team
Project leader: Ioan-Ovidiu Sirbu, MD, PhD, Associate Professor
Senior researchers: Catalin Marian, MD, PhD, Professor
Mihaela Simu, MD, PhD, Professor
Technician: Cristina Bejinar, MSc
Results
We have validated a set of three plasma microRNAs statistically associated Parkinsons disease in both female and male patients.
Name Fold change Pvall
miR-A 1.26 0.015
miR-B 1.23 0.028
miR-C 1.47 0.005
Our analysis of age and gender specific epression of these three microRNAs in WT mice reveals organ, gender and age specific expression patterns, which partially correlates with the age and gender analysis performed in humans. A second (ongoing) analysis of the corresponding pri-miR expression will provide info upon the transcriptional aspects of microRNA regulation in these organs.
Here is the final analysis (91 participants) of the entire set of 15 microRNAs
Name Fold change Pvall
miR-A 1.27 0.011
miR-B 1.24 0.022
miR-C 1.47 0.005
miR-16 1.1 0.197
miR-92a 1.26 0.071
miR-576-5p 1.33 0.134
miR-16-2* 0.96 0.854
miR-941 1.12 0.702
miR-363 1.16 0.517
miR-454 0.95 0.836
let-7e 0.93 0.770
let-7c 0.96 0.882
let-7b 1.09 0.694
miR-93* 0.88 0.5454
miR-1976 0.67 0.170
Characterization
of diagnostic tests for the 3 plasma microRNAs associated to Parkinson's disease
miR-A
Sensitivity (CI 95%) 91.04 (81.5-96.6)
Specificity (CI 95%) 32.35 (17.4-50.5)
Accuracy (CI 95%) 71.29 (61.4-79.9)
miR-B
Sensitivity (CI 95%) 89.39 (79.4-95.6)
Specificity (CI 95%) 31.43 (16.9-49.3)
Accuracy (CI 95%) 69.31 (59.3-78.1)
miR-C
Sensitivity (CI 95%) 74.24 (62.0-84.0)
Specificity (CI 95%) 57.14 (39.4-73.7)
Accuracy (CI 95%) 68.32 (58.3-77.2)
Age specific variations of mature miR-B and miR-C in the brain of WT mice
miR-C (ratios to neonatal value)
Age Fold change Pvalue
3m 2.53 0.002
6m 8.88 0.002
9m 2.59 0.012
21m 9.58 0.017
miR-B (ratios to neonatal value)
Age Fold change Pvalue
3m 0.04 0.002
6m 0.01 0.00005
9m 0.005 0.03
21m 0.06 0.001
Bioinformatics analysis (miRWalk3.0/David) of miR-A, miR-B and miR-C targets
KEGG path Pval Enrichment Benjamini
hsa04022 5.9E-05 1.5 0.017
hsa04015 1.09E-04 1.44 0.016